CNH Industrial N.V. (NYSE: CNH) — The Permanent Number Two, Marked Down to the Trough of a Generation

Independent equity research — initiation. Report date: 2026-07-17 · Price at analysis: ~$10.64 Sector: Industrials · Agricultural & Construction Machinery

⚡ Claude’s Take

This block is the author’s own independent opinion and general information only — not investment advice. The analysis in sections 1–15 below is deliberately written without a recommendation or price target; this block is the single, fenced-off exception where a directional view is expressed.

Verdict: HOLD — a cheap, out-of-favor cyclical worth accumulating on weakness (below ~$10, i.e. ≤~7.5x normalized), not chasing. Not a short. Fair value ~$13–15 on ~$1.35 mid-cycle EPS at ~10–11x. Conviction: medium.

Tag: “Cheap for a reason, but priced as if the reason is permanent.”

CNH is a genuinely mediocre franchise selling at a genuinely cheap price at the bottom of a generational agricultural down-cycle — and those three facts are the whole story. This is the structural number two to Deere: at the same cyclical trough, CNH earned a 4.3% industrial EBIT margin against Deere’s ~12–13%, spends less than half of Deere’s R&D dollars, had to buy its precision-agriculture stack (Raven, 2021, ~$2.1B — since partially written down), and is tilted toward the lower-margin European and Brazilian markets rather than Deere’s fortress in North American large-ag. You should never confuse it with Deere, and the market doesn’t: CNH trades at 0.73x sales versus Deere’s 4.6x, and that discount is deserved. The bull case is not that CNH is secretly great; it’s that at ~$10.64 you are paying roughly 8x normalized mid-cycle earnings for a durable #2 in a rational oligopoly, with a sound industrial balance sheet (~$2.0B net debt), a self-help margin program, Construction-disposal optionality, and a controlling owner (Exor) whose interests are aligned with patient value creation. The 34x trailing P/E is a denominator illusion — earnings are at a ~20–30-year unit-volume low. On my ~$1.35 normalized EPS, the market at $10.64 is pricing in only ~$1.00 of through-cycle earnings power, i.e. a skeptical, structurally-discounted partial recovery — not the trough-as-permanent (that would be ~$6), and not a full normalization (that would be ~$14–15).

The reason it’s a HOLD and not a table-pounding buy: the catalyst hasn’t arrived. Farm income and crop prices — the actual demand trigger — have not turned, management has guided FY2026 to a second, lower trough (industrial margin 2.5–3.5%), Brazilian credit is deteriorating inside the captive finance book (delinquencies 1.9%→3.1%→~3.5%), and there is zero insider open-market buying at these lows despite management’s own “trough of a generation” language — a conspicuous silence. The factor tape confirms the framing: this is an abandoned-value cyclical with negative momentum and a negative Sharpe across every window from six months to five years, only now base-building. That is exactly the setup that is asymmetric if the cycle turns in 2027 — and a value trap if it doesn’t. Flips bullish on a North American large-ag order-book/retail inflection into 2027 with Ag margins recovering toward low-teens. Flips bearish on a third/fourth guidance cut, FY2027 industrial margin still stuck below 5%, or evidence of permanent share loss to Deere’s precision stack. Own it small, add lower, and get paid ~1% to wait for the cycle.

📈 Stock Price Action — Five-Year Event Map

Over the past five years CNH round-tripped an entire agricultural cycle: from ~$11 in early 2021 up to a ~$18 peak in early 2023 (the ag super-cycle high), then a grinding ~40%+ de-rate back to single-digit lows (~$9.2 in December 2025) as farm income, crop prices and dealer orders rolled over. At ~$10.64 (2026-07-17) the stock sits near the low end of its five-year range — roughly 41% below the February-2023 high (~$17.9), inside a 52-week range of ~$9.22–$13.38, and trading just under its 200-day EMA (~$10.78). (All price levels are FACT from the AZI daily price series; the cycle attribution is INTERPRETATION.)

Cycle narrative. (1) 2021 rode the post-COVID reflation and a farm-income boom. (2) The January-2022 Iveco demerger left CNH a pure agriculture + construction + captive-finance play, shedding the volatile on-highway truck stub. (3) 2022 macro fear de-rated the multiple even as earnings stayed strong. (4) The October-2022 → February-2023 surge to ~$18 marked the ag-cycle earnings peak (FY2023 EPS $1.69). (5)–(6) From early 2023 the classic ag down-cycle set in — falling crop prices → falling farm income → dealer destocking → repeated guidance cuts through 2024. (7)–(8) A mid-2025 bounce faded into a deeper trough as FY2025 EPS cratered to $0.41 and FY2026 was guided to a 2.5–3.5% industrial EBIT margin. (9) 2026 year-to-date is base-building in the high-$9s/low-$10s. (Price moves are FACT from the AZI price series; the attributed causes are INTERPRETATION, cross-referenced to earnings prints, the Iveco 8-K, guidance changes and the ag cycle. No price target, no support/resistance, no chart-pattern claims.)

1. Executive Summary

CNH Industrial is the world’s clear number-two full-line agricultural equipment manufacturer — Case IH and New Holland in agriculture, CASE in construction, and a captive finance arm (CNH Industrial Capital) — sitting behind Deere & Company in every dimension that matters to economics. The investment question is not whether CNH is a great business (it is not) but whether, at ~$10.64 and roughly 41% below its cycle high, the price already discounts its second-tier reality plus a deep, possibly extended, agricultural down-cycle.

The business. FY2025 revenue was $18,095M — Agriculture $12,390M (68%), Construction $2,956M (16%), Financial Services $2,720M (15%). Industrial net sales of $15,346M are down 30% from the FY2023 peak of $22,080M. Unusually versus Deere, CNH’s agriculture business is EMEA-heaviest (37% of ag sales) with only ~35% in North America and ~16% in South America — it captures far less of the profit-rich NA large-ag pool and far more of lower-margin Europe and cyclical Brazil.

The moat, and its limits. CNH has the same type of moat as Deere — economies of scale, dealer-network density, parts/service switching costs, brand — but at roughly half the scale and one-third the trough margin. The clinching statistic: at the same 2025 cyclical bottom, CNH’s industrial EBIT margin was 4.3% (Agriculture 6.2%, Construction 2.3%) against Deere’s ~12.6% equipment-operations margin. CNH spends $1,025M on R&D against Deere’s $2,310M, and it bought rather than built its precision-ag capability (Raven, ~$2.1B in 2021), taking a $172M in-process-R&D impairment against that deal in FY2025. This is a durable but narrow moat — one that protects survival and a persistent #2 share, not premium economics.

The cycle. This is a deep, low-quality earnings trough. Net income fell from $2,275M (FY2023) to $510M (FY2025), a ~78% collapse — proportionally deeper than Deere’s ~50% because CNH’s thin margins amplify the cycle. Management calls 2026 “the trough… probably in like 20 or 30 years of ag,” and has guided FY2026 to a second, lower industrial margin of 2.5–3.5% and adjusted EPS of just $0.35–0.45. TTM GAAP EPS is ~$0.31, making the 34x trailing P/E a pure denominator illusion.

Valuation. On the only figure that matters for a cyclical — normalized mid-cycle earnings — we estimate ~$1.35 of EPS power (range $1.25–1.45). At $10.64 the stock trades at ~7.9x that figure, versus CNH’s own through-cycle ~9–12x and Deere’s ~13–14x. Reversed, a fair ~10.5x mid-cycle multiple implies the market is currently pricing only ~$1.00 of normalized earnings — a skeptical, structurally-discounted partial recovery, roughly halfway between trough and full normalization. CNH is the cheapest of Deere/CAT/AGCO on price-to-sales (0.73x) and near-cheapest on price-to-book (1.70x, the 19th percentile of its own history).

Verdict. A cheap, abandoned cyclical value name at a genuine trough, held back by a genuinely second-tier franchise, a Brazilian-credit soft spot, and the absence of any near-term demand catalyst. The dominant risk is a value trap / longer-trough drag, not solvency — the industrial balance sheet (~$2.0B net debt) is sound. The entire debate reduces to whether normalized earnings power is ~$1.00 (the market’s implied view) or ~$1.35+ (the bull case). No recommendation and no price target follow in this body; the position is taken only in Claude’s Take above.

2. Business Overview

CNH Industrial N.V. is a Netherlands-domiciled (Amsterdam-headquartered, with major operations in Basildon, UK and across Europe/the Americas), USD-reporting global manufacturer of agricultural and construction equipment, plus the associated captive financing. It reports as a U.S. domestic filer (Form 10-K; it transitioned from foreign-private-issuer 20-F/6-K status around 2023). The company was created from the 2013 combination of Fiat Industrial and CNH Global, and — critically for any historical analysis — demerged its Iveco Group (on-highway trucks, buses, and powertrain) business on 3 January 2022. Pre-2022 income statements (FY2019 revenue ~$28.1B, FY2020 ~$14.8B) include Iveco and are not comparable to today’s continuing operations; all trend analysis in this memo uses the post-Iveco base from FY2022 onward.

Three reportable segments — but two economic entities. CNH, like Deere, is best understood as a manufacturer bolted to a bank:

• Agriculture — FY2025 net sales $12,390M (68% of total revenue). The crown jewel. Products span two-wheel and four-wheel-drive tractors, crawler tractors, combines, grape/sugar-cane harvesters, hay and forage equipment, planting/seeding, tillage, material handling, and precision-agriculture technology. Brands: Case IH (premium, row-crop, strong in North America and Brazil), New Holland Agriculture (value-to-mid, dominant in Europe and hay & forage), STEYR (European regional small/mid tractors), and Raven (global precision-tech).
• Construction — FY2025 net sales $2,956M (16%). Excavators, dozers, graders, wheel/backhoe/skid-steer loaders, compact track loaders under CASE Construction Equipment, New Holland Construction, and Eurocomach (compact; acquired via Sampierana, 2024). A distant also-ran versus Caterpillar and Komatsu, structurally sub-scale, and — importantly — now under a formal strategic review for a possible sale, partnership, or JV (see ).
• Financial Services — FY2025 revenue $2,720M (15%), managed portfolio ~$28.6B. The captive lender (CNH Industrial Capital / Banco CNH in Brazil) finances end customers and dealers, provides retail installment and wholesale floor-plan financing, and operates revolving-charge programs. It is match-funded via securitizations and unsecured notes.

Together, Agriculture + Construction constitute “Industrial Activities” (FY2025 net sales $15,346M), which CNH reports on a distinct basis from Financial Services. This two-activity structure is the single most important analytical fact about the company: consolidated debt (~$26.8B gross, ~$23.4B net) is dominated by the finance arm’s funding book and must never be read as industrial leverage.

Revenue composition. FY2025 revenue by source: sales of goods $15,290M; services $56M; finance and interest income $2,132M; rental/operating-lease income $617M — so ~85% whole-goods and ~15% finance/lease. CNH, like Deere, does not separately disclose aftermarket/parts revenue, which obscures the size and stability of the highest-margin, most-recurring part of the business. Distribution runs through ~2,300 agriculture dealers / 5,000+ points of sale and ~400 full-line construction dealers, versus Deere’s much denser North American network (~2,050 US/Canada locations, ~1,600 ag). CNH employs ~34,200 people. The CEO is Gerrit Marx (formerly CEO of Iveco); the CFO is A.J. (James) Nickolas; the chair is Suzanne Heywood. Exor N.V. (the Agnelli family holding company) is the controlling anchor shareholder with 29.6% economic and 45.5% voting ownership.

Verdict. A diversified global #2 agricultural-equipment franchise with a value-to-premium brand ladder and captive finance — but a revenue base roughly half of Deere’s equipment sales, structurally tilted away from the most profitable pool (North American large ag) and toward Europe (New Holland’s stronghold) and cyclical Brazil. Whole-goods-heavy, with the recurring aftermarket annuity undisclosed and therefore unverifiable.

3. Industry Dynamics

Structure — a good oligopoly in agriculture. The global agricultural-equipment industry is a concentrated oligopoly with formidable barriers to entry. Deere is the clear #1 (~50–60% of North American large tractors and combines); CNH is #2 (Case IH / New Holland); AGCO is #3 (Fendt / Massey Ferguson / Valtra); Kubota leads small-ag/compact at low cost; CLAAS and Mahindra round out the field. The barriers — dealer density, brand, emissions-compliance R&D scale, precision-technology integration, and capital intensity — are real and self-reinforcing, and they favor scale incumbents. Pricing is broadly rational; the majors compete on product, dealer support and technology rather than on destructive price wars. This is a structurally attractive industry — the kind of concentrated, high-barrier profit pool that rewards the leader handsomely and the #2 adequately.

Where we are in the cycle — a deep trough. The industry is in a severe down-cycle, the mirror image of the 2021–2023 boom. CNH’s own FY2025 industry-volume disclosures: North American tractors >140hp down 33% year-over-year, tractors <140hp down 7%, combines down 26%; EMEA tractors −13%, combines −3%; South America tractors −1%, combines −16%. This tracks Deere’s ~30% NA large-ag industry decline in the same period. The demand driver is net farm income, and it has not turned: the USDA’s February-2026 forecast puts 2026 U.S. net farm income at $153.4B, down 2.6% in real terms, with crop-profit margins the poorest since 2016–2020, corn around $4.20/bushel and soybeans ~$10.40 — well off the 2022 highs that fueled the equipment boom, and propped up in part by government payments.

The Marathon capital-cycle read. The supply side is favorable and classically Marathon-esque: the majors are under-producing relative to retail demand (CNH ~4% underproduction planned for 2026; ~$800M of dealer inventory cut in FY2025 with ~$500M more planned in 2026), the used-equipment glut is draining, and the installed fleet is aging into a coiled replacement wave. This is the disciplined-supply-into-eventual-recovery inflection that historically precedes cyclical earnings recoveries. But the demand trigger (farm income / crop prices) has not inflected, and CNH executes this playbook from a weaker position than Deere: its thinner margins mean a deeper, longer earnings trough, and its heavy Brazil exposure adds a credit and FX dimension Deere largely lacks. Both companies’ managements converge on the same timing: 2026 is the bottom; recovery, if it comes, is a 2027+ story.

Construction — a structurally poor industry for CNH. Construction equipment is far less attractive for a sub-scale player. Caterpillar (~16%) and Komatsu (~11%) dominate; Chinese OEMs XCMG and SANY are gaining aggressively on price (especially in China/APAC, where CNH cites weakness); Deere (~5%) and Volvo CE are mid-tier. CNH is sub-scale, earning a 2.3% trough EBIT margin on ~$3B of revenue — which is precisely why it is a divestiture candidate.

Regulation. Emissions standards (Tier 4 / Stage V, and forthcoming tighter regimes) raise R&D and compliance barriers that favor scale incumbents — moat-reinforcing, but a disadvantage for CNH given Deere’s ~2x R&D budget. Right-to-repair is a live threat to the captive-parts annuity across the whole industry: the FTC and five state attorneys general sued Deere in January 2025 over repair restrictions (an antitrust MDL in the Northern District of Illinois), and CNH’s own dealer-locked parts/repair economics are exposed to the identical regulatory vector. Tariffs are a FY2025–2026 cost headwind hitting both segments’ margin bridges.

The replacement-demand arithmetic. The bull’s “coiled spring” is quantifiable. North American large-ag equipment has an economic life of roughly 8–12 years, implying a steady-state replacement rate of ~8–12% of the installed fleet annually. When retail demand runs 30%+ below trend for two-to-three consecutive years — as it has in 2024–2026 — the fleet ages past its normal replacement point, deferring (not destroying) demand. Deere has quantified this: its NA 220hp+ tractor field inventory sits at a 17-year low, and it is under-producing retail by ~10%. CNH’s ~4% planned 2026 underproduction and ~$800M+$500M dealer destock are the same mechanism at smaller scale. The Marathon read is unambiguous on the supply side — capacity is being restrained precisely when the fleet is aging into pent-up need. What is missing is the demand trigger: farmers replace when their income and balance sheets permit, and USDA’s depressed 2026 farm-income and crop-margin forecasts say that trigger has not flipped. This is why both Deere and CNH frame 2027 — not 2026 — as the earliest recovery, and why the timing (not the existence) of the eventual snap-back is the whole debate. (Interpretation, grounded in USDA data and both OEMs’ disclosures.)

Verdict. Agriculture is a structurally good industry (concentrated, high-barrier, rational, currently at a favorable supply-disciplined trough). Construction is a structurally poor industry for CNH (fragmented, Chinese-pressured, sub-scale). On a blended basis, CNH occupies the #2 chair in a good industry, capturing less of the profit pool than Deere and skewed to lower-margin geographies — a good industry, mediocre position.

4. Competitive Position

Name the moat, then measure it. In Greenwald’s taxonomy, CNH’s competitive advantage is the same type as Deere’s: economies of scale combined with customer captivity (dealer-network density, parts and service switching costs) and brand intangibles. A farmer who buys a Case IH combine is locked into Case IH dealers for parts, service, and eventually trade-in; the dealer network is expensive to replicate; the brands carry a century of trust. This is a genuine, durable moat. The problem is entirely one of degree.

The killer statistic — trough margins. A wide moat reveals itself in trough-year returns, when a business’s structural advantages are tested. Here CNH fails the comparison decisively. In FY2025, both CNH and Deere sat at the cyclical bottom, and:

CNH earns roughly one-third of Deere’s operating margin at the same point in the cycle, and spends less than half the R&D dollars — the core self-reinforcing input to the precision-ag and emissions-compliance advantage. A moat that leaves you with a 4.3% margin at the trough, while your larger rival earns ~12.6%, is a narrow moat.

Precision agriculture — a bought, following position. The next decade’s competitive battleground is precision/digital agriculture (autonomy, guidance, spray-by-plant, connected fleet management, data). Deere built its stack organically over 20 years — JDLink, See & Spray, and the Operations Center, which manages 500M+ engaged acres with ~440,000 monthly active users, a genuine data network effect. Third-party estimates put Deere’s precision-ag share at ~15–18%, AGCO at ~7–9%, and CNH lower and unquantified. CNH does not disclose a comparable engaged-acres or MAU figure — itself a tell that its digital installed base is smaller and less monetized. Tellingly, CNH had to buy its way toward parity: Raven Industries (November 2021, ~$2.1B, $58/share, targeting ~$400M of revenue synergy by 2025), plus Augmenta (computer-vision spraying), Hemisphere GNSS (positioning), and Bennamann (biomethane). Management’s “Iron + Tech” strategy is, in plain terms, an acknowledgment that CNH was behind and had to purchase the capability — and the FY2025 $172M IPR&D impairment against Raven/Bennamann is direct evidence the capability was bought at a full price and has not yet earned its keep. The forward plan (Tech Assist AI diagnostics at ~70% of dealers, FieldOps, green-on-green spraying via One Smart Spray in 2027, target to roughly double precision content to ~10% of ag sales by 2030) is a credible catch-up build-out — but it is a follower’s roadmap, not a leader’s moat.

Moat tests. On Greenwald’s market-share-stability test, CNH passes as a persistent #2 — New Holland is entrenched in Europe and hay/forage, Case IH in row-crop and Brazil, and these positions are durable. But it does not dominate any large pool the way Deere dominates NA large ag. On the ROIC test, CNH’s trough returns (4.3% industrial margin, single-digit industrial ROIC at the bottom) sit near its cost of capital — a real but narrow moat, not the wide fortress Deere clears decisively.

The parts-and-dealer annuity — where the moat actually lives. The economically valuable part of CNH’s moat is not the whole-good sale (a competitive, cyclical, thin-margin transaction) but the multi-decade tail that follows it. A Case IH combine sold today generates 15–20 years of parts, service, and eventually a trade-in and replacement, nearly all captured by the selling dealer’s network. Aftermarket parts carry margins well above new-equipment margins across the industry, and they are far more stable — a farmer defers a new-tractor purchase in a down-year but cannot defer repairing the machine that harvests the crop. This is a genuine Greenwald customer-captivity moat, and it is the single best reason to believe CNH’s normalized margins are higher than its 4.3% trough. The problem for a #2: the annuity scales with the installed base, and CNH’s installed base is roughly half Deere’s, so the absolute parts-profit pool it defends is proportionally smaller — and the undisclosed aftermarket line means investors cannot verify whether that annuity is growing, stable, or quietly eroding to right-to-repair and independent-parts channels. The right-to-repair regulatory push (the FTC/state-AG suit against Deere) is a direct attack on exactly this annuity; CNH sits behind Deere in the blast radius, not outside it.

Why density caps a #2. Dealer density is a reinforcing advantage that structurally favors the leader. A farmer values proximity — a dealer that can deliver a part or a service technician within hours during a narrow planting or harvest window. The OEM with the densest network wins the marginal sale, which funds more dealers, which deepens the density advantage. Deere’s ~1,600 North American ag locations versus CNH’s thinner coverage means Deere wins more of the marginal large-ag sale in the highest-value region — and CNH’s own 2030 plan (cutting first-level dealer owners by a third, pushing to 60% dual-brand) is an explicit attempt to consolidate its network into fewer, stronger, better-capitalized dealers to narrow that gap. It is a sensible response, but it is a response from behind.

Verdict. A durable but narrow moat. CNH is a genuine structural #2 with a dealer/parts/brand advantage of the same kind as Deere’s, but at roughly half the scale, one-third the trough margin, less than half the R&D, and a bought-not-built precision-ag position that trails both Deere and AGCO on disclosed share. The market prices this precisely — 0.73x sales versus Deere’s ~4.6x. Stated directly: CNH’s moat protects its survival and its persistent #2 share, not premium economics.

5. Growth History and Forward Opportunities

History — a levered play on the ag-capex cycle, not a compounder. Post-Iveco continuing-operations revenue ran $23,551M (FY2022) → $24,687M (FY2023 peak) → $19,836M (FY2024, −19.6%) → $18,095M (FY2025, −8.8%), a peak-to-trough decline of ~27% in two years. The segment detail is starker:

Earnings fell far more than sales — the signature of operating deleverage in a fixed-cost manufacturer. Net income went $2,275M → $1,246M → $510M (−78%), diluted EPS $1.69 → $0.99 → $0.41, and Agriculture’s adjusted EBIT margin compressed 830bps (14.5% → 6.2%). The ~78% earnings collapse is proportionally deeper than Deere’s ~50%, precisely because CNH’s thinner margins leave less cushion.

The quality of that growth. There is no secular organic compounding here. The top line is pure ag-capex cyclicality — NA large-ag industry volumes fell 33% in 2025 — and the “growth investments” (Raven, Augmenta, Hemisphere, Sampierana) are acquired capability to defend the #2 position, not organic engines. The one bright spot in FY2025 was EMEA agriculture, up 8.1% (Europe less depressed than North America), and in Q1’26 EMEA ag rose ~20% — a sign New Holland’s home market may lead any recovery. But the aftermarket/precision revenue that would constitute a durable, recurring growth annuity is not separately disclosed, so its scaling cannot be verified.

Forward opportunities. Three, in ascending order of speculativeness. (1) Cyclical recovery — whenever farm income turns (2027+?), operating leverage works powerfully in reverse: a return of NA large-ag volumes plus production normalizing to retail (a ~4% absorption tailwind by management’s math) would drive a sharp margin and EPS recovery. (2) Self-help margin program — CNH is targeting $550M of cumulative cost-out by 2030 (~$230M already taken from Agriculture in FY2025), with a stated 2030 Agriculture mid-cycle EBIT-margin target of 16–17%, i.e. closing much of the gap to Deere. (3) Precision-ag monetization — doubling precision content to ~10% of ag sales by 2030, with FLEETPRO all-makes retrofit kits and a heavy launch cadence. Each is real; none is proven in the disclosed numbers yet.

Verdict. Low-quality, deeply cyclical growth. The top line is a levered bet on the ag-capex cycle, currently ~27–30% below the FY2023 peak with a ~78% net-income collapse. Forward “growth” is (a) cyclical recovery on an as-yet-unturned demand trigger and (b) bought-in precision-ag/aftermarket ambitions plus a self-help margin story that must still show up in the P&L. CNH is a cyclical trough story, not a compounder — the growth case is entirely about the slope and timing of the next recovery, not a secular curve.

6. Financial Quality

First, separate the two companies. The single most common and most costly error in analyzing CNH is to treat consolidated leverage as corporate leverage. The FY2025 10-K’s “Reconciliation of Net Debt to Total Debt” makes the split explicit:

The Industrial business carries only ~$2.0B of net debt (worsened $298M YoY as the down-cycle and capital returns absorbed FCF) — modest, roughly 0.7x on ~$2.8B of mid-cycle industrial EBITDA. The Financial Services book’s $21.4B is match-funded against ~$28.6B of managed finance receivables; it is a spread business, not corporate leverage. Any aggregator EV of ~$36–38B and consolidated EV/EBITDA of ~11.7x that counts the finance funding as industrial debt is analytically meaningless (see ). Solvency is not the risk here; the industrial balance sheet is sound.

Margins and the trough. The cyclical collapse is stark:

FY2026 is guided lower still — industrial EBIT margin 2.5–3.5% — making 2026 a second, deeper trough than 2025. Consolidated gross margin held around 31–33% (blended with FS), but operating margin fell 20.0% → 15.5% as volume evaporated.

Quality-of-earnings red flags. Several items make FY2025’s already-thin GAAP earnings lower quality than they look:

1. The finance arm carried the company. Of FY2025’s $505M consolidated net income, Financial Services contributed $333M — leaving only ~$172M from all of manufacturing. At the trough, the captive lender out-earned the entire industrial business. Group EPS is being propped by the finance book.
2. FCF was destock-flattered. Industrial free cash flow ran $1,216M (FY2023) → negative $401M (FY2024) → $513M (FY2025). The FY2025 figure was flattered by a large inventory-destocking working-capital release (consolidated inventory change ~+$749M) — a one-time source of cash, not durable generation. Q1’26 industrial FCF was a $569M seasonal absorption; the full-year 2026 guide is just $150–350M. When production normalizes to retail, the inventory rebuild will consume cash — the destock tailwind is finite and about to reverse.
3. A Raven write-down. The $172M non-cash IPR&D impairment (Raven + Bennamann) validates the “bought-not-built, overpaid on precision” thesis.
4. An Argentina tax one-off. FY2025 Financial Services taxes were favorably affected by a non-recurring prior-year valuation-allowance adjustment in Argentina — a one-time benefit flattering the already-load-bearing FS earnings. LatAm/Argentina FX and hyperinflation (IAS-29-type) accounting are a recurring distortion of reported results.
5. Rising credit costs (detailed below).

Returns — flattered by leverage. Consolidated ROE ran 42.3% (FY2021) → 31.8% → 25.8% → 12.5% → 4.9% (FY2025); ROIC 11.6% (FY2023) → 7.3% → 4.9%. The peak ROEs are finance-leverage artifacts — a thin ~$7.8B equity base levered by ~$27B of (mostly FS) debt. Tangible book value is only ~$2.50/share (goodwill $3.6B + intangibles $1.1B against $7.8B equity). CNH’s own LTI targets “Industrial RoIC,” which at a 4.3% trough industrial EBIT margin sits near or below the cost of capital. This is not a compounder’s return profile.

Financial Services credit quality — the live watch-item. FS net income was $333M (FY2025) versus $379M (FY2024), the decline driven by “higher risk costs from increased specific reserves and delinquencies in South America.” The flag: receivables >30 days past due rose to 3.1% at YE2025 from 1.9% at YE2024 (a +120bps jump), and further to ~3.5% by Q1’26 — “due to economic and environmental factors impacting farmers, specifically in South America.” Brazil is the soft spot. The book is match-funded and reserved, so this is not yet a solvency issue, but it is a rising-risk-cost drag on the very segment carrying group earnings — worth watching net charge-offs against the reserve build.

The decremental-margin math — why the trough is so deep. The severity of CNH’s earnings collapse is a direct function of operating leverage. From FY2023 to FY2025, industrial net sales fell $6,734M ($22,080M → $15,346M) and industrial adjusted EBIT fell ~$2,211M ($2,874M → $663M) — a decremental margin of ~33%, meaning roughly a third of every lost sales dollar fell straight through to lost EBIT. That is the signature of a business with high fixed manufacturing and engineering costs and limited ability to flex them down in a downturn. The same leverage works in reverse on the way up: if CNH recovers ~$3B of industrial sales toward mid-cycle at a ~30% incremental margin, that is ~$900M of EBIT — roughly $0.55–0.65 of pre-tax EPS recovery — which is precisely the mechanism behind the ~$1.35 normalized figure. The self-help cost program matters here because it is an attempt to raise the incremental margin (and lift the whole margin curve), so that the next up-cycle converts more of each recovered sales dollar into profit than the last one did. Whether it succeeds is the central operational question in the bull case.

The finance-book spread economics. Financial Services is easy to mis-model. It is a ~$28.6B managed receivables book funded by ~$21.4B of match-funded debt plus equity, earning a net interest spread minus credit costs. FY2025 FS net income of $333M on ~$3.5–4B of allocated equity is a ~9% return — respectable and counter-cyclical in revenue (the book keeps earning spread even as equipment sales collapse), which is exactly why it carried group earnings at the trough. The catch is that it is pro-cyclical in credit costs: as farmer balance sheets deteriorate, delinquencies and reserves rise (1.9% → 3.1% → ~3.5% past-due, Brazil-led), compressing the spread. So FS is a stabilizer on the top line and a partial de-stabilizer on the bottom line at the trough — a nuance the “captive finance smooths earnings” cliché misses. It should be valued separately, near its allocated equity, and never consolidated into an industrial EV or leverage figure.

Verdict. Economics do not improve with scale the way Deere’s do. CNH is a subscale #2 whose trough industrial margin (4.3%, guided lower to 2.5–3.5% in FY2026) is ~one-third of Deere’s, whose reported returns are flattered by finance leverage and an Argentina tax one-off, whose FY2025 FCF was destock-flattered, and whose group net income at the trough came mostly from the captive finance arm. The industrial balance sheet is sound (~$2.0B net debt); the risk is earnings quality and cyclicality, not solvency. This is a deep, low-quality trough — which is exactly what creates the cheapness, and exactly what makes the recovery slope the whole question.

7. Capital Allocation

Capital-return scorecard. CNH’s through-cycle capital return has been disciplined and correctly pro-cyclical — a genuine positive:

As the cycle rolled over and industrial FCF turned thin, management slashed buybacks from $702M (2024) to $100M (2025) and cut the dividend from $607M to $333M (FY2025 declared ~$0.25/share) — protecting the balance sheet rather than defending a fixed payout into the trough. Diluted share count fell from 1,362M (FY2022) to 1,251M (FY2025), ~7.6% / ~102M shares retired. The one mild demerit: buybacks were skewed toward the higher-price years (2023–24) rather than the 2025–26 lows — a common but value-neutral-to-negative timing pattern. Net: prudent stewardship through a brutal cycle, not value-accretive on timing.

M&A — the Raven blemish. The marquee capital-allocation decision of the past cycle was Raven Industries (~$2.1B, 2021) — the big precision-ag bet, at roughly 30–40x pre-deal EBITDA — plus the smaller Augmenta, Hemisphere, Bennamann, and Sampierana/Eurocomach deals (FY2025 acquisition spend $312M). The FY2025 $172M IPR&D impairment against Raven/Bennamann is a partial admission that the precision-ag capability was overpaid and remains a follower to Deere’s organically-built stack. Strategically necessary (CNH had to close the precision gap), but expensive and not yet earning its keep in the numbers — a value-neutral-to-negative outcome so far.

R&D and CapEx. R&D of $1,025M (FY2025, ~6.7% of industrial sales) is respectable as a percentage but less than half Deere’s ~$2.3B in absolute dollars — the moat-input gap compounds over time. Industrial CapEx was $530M (FY2025), guided up to $600–650M in 2026 as management retools during the slow period (counter-cyclical, defensible if the recovery arrives, a risk if the down-cycle extends).

Funding. The June-2026 $600M 4.950% CNH Industrial Capital notes (and C$450M Canadian notes) are Financial Services funding matched to the receivables book — not incremental industrial leverage, and should not be read into the industrial-leverage picture.

Incentive alignment — genuinely good. The 2026 proxy shows a well-constructed plan. Short-term incentive: 40% consolidated adjusted EBIT margin, 20% constant-FX revenue, 20% cash-conversion ratio, 10% CO₂, 10% safety — and crucially, the EBIT-margin component paid 0% in 2025 because actual (6.0%) fell below the funding hurdle, so the metrics actually bite. Long-term (3-year PSU): 50% adjusted diluted EPS + 50% Industrial RoIC, modified by relative TSR, capped at 200%; the CEO’s LTI is 100% PSUs held to the fifth anniversary. These are the right metrics — margin, cash, return-on-capital, relative shareholder return — not a rubber stamp. CEO Marx’s FY2025 total comp was $11.72M; CFO Nickolas $12.3M (including a $4.5M make-whole sign-on); say-on-pay passed with 96.15% support. Exor’s 45.5% voting control is a governance overhang for minorities but aligns the largest owner with long-term value and lowers forced-sale risk. There is, notably, zero insider open-market buying across the Form-4 corpus at these lows — no code-P purchases — a conspicuous absence given management’s “trough of a generation” narrative.

Verdict. An adequate-to-good allocator, not a distinguished one. Positives: disciplined pro-cyclical throttling of buyback and dividend to protect the balance sheet; the right incentive metrics (Industrial RoIC / margin / cash) that genuinely constrained payouts in 2025; a ~7.6% share-count reduction; a sound industrial balance sheet. Negatives: Raven partially impaired and a follower’s price; buybacks skewed to higher-price years; group earnings dependent on the captive finance arm; and no insider conviction buying at the lows. Prudent stewardship through the cycle, but the signature decision (Raven) is so far value-neutral at best.

8. Changes and Headwinds — Last Two Years

Strategic. The defining structural change was the January-2022 Iveco demerger, which left CNH a pure agriculture + construction + captive-finance company (predating the two-year window but foundational to today’s structure). Within the window, the most consequential development is the Construction strategic review: management “restarted discussions with several players about the partnering options for our Construction business” (Q4’25) and expects clarity “over the course of the remainder of 2026 or first half of 2027,” explicitly noting CE “does not necessarily have to be in our ownership.” A sale, JV, or partnership of the ~15%-of-industrial-sales, 2.3%-margin construction unit would sharpen the portfolio toward the higher-quality ag business — real optionality, with attendant M&A headline risk and a possible below-book impairment if sold cheaply (Construction goodwill has not been written down).

Operational. A May-2025 Investor Day set 2030 targets (Agriculture mid-cycle EBIT margin 16–17%, $550M cost-out, precision to ~10% of sales, dealer-network consolidation cutting first-level owners by one-third with 60% dual-brand by 2030). The self-help program is underway — ~$230M of ag cost taken in FY2025 (quality-cost, lean-manufacturing, strategic sourcing), ~10%+ of white-collar headcount removed in late-2023/early-2024, and the Burlington, Iowa construction plant closing by Q2 2026 (production shifting to Wichita, Kansas). November 2025’s Agritechnica showcased a refreshed European tractor lineup and next-gen combines.

Leadership. CEO Scott Wine departed and Gerrit Marx (ex-Iveco) succeeded him; the CFO seat is held by A.J. Nickolas. The May-2026 AGM re-appointed Marx and chair Heywood and approved the dividend and buyback authorizations.

Headwinds. (1) The deepening ag trough — FY2026 guided below FY2025. (2) South America — Q1’26 SA ag sales fell 28%, the SA recovery thesis that management once expected to lead has broken (tighter Brazilian credit, delayed Plano Safra farm-bill payouts, election-year “wait-and-see”), and SA is the credit soft spot in Financial Services. (3) Tariffs — a net-negative price/cost headwind in Construction for 2026 and a margin drag in Agriculture. (4) Financial Services delinquencies rising toward ~3.5%. (5) JPMorgan downgraded CNH to Underweight (PT $10, maintained 2026-07-13) on farm-equipment and tariff caution.

Verdict. On balance these developments modestly strengthen the long-term thesis while confirming near-term pain. The self-help program and Construction-review optionality are genuine positives that could lift through-cycle margins and sharpen the portfolio; the leadership transition is orderly. But the demand environment has deteriorated since 2024 — a second, lower guided trough, a broken South America recovery, and rising captive-book credit costs. The thesis is strengthened structurally and weakened cyclically at the same time — which is the essence of a trough investment.

9. Risk Analysis

Catastrophic-loss assessment. The risk of a catastrophic or total loss is low. The industrial balance sheet is sound (~$2.0B net debt), the assets are real, revenue is ~$18B, and even trough FCF is positive. The captive finance book is match-funded and reserved. The dominant risk is not solvency but a value trap / longer-trough drag — the stock staying cheap and dead-money for an extended period if farm income fails to inflect, compounded by the possibility that CNH’s normalized earnings power is structurally lower (~$1.00) than the bull case assumes (~$1.35+). A secondary tail is a disorderly Brazilian credit event in Financial Services, which would hit the one segment currently carrying group earnings.

10. Valuation Discussion (Embedded Expectations)

Trough P/E is meaningless — this is a normalized-earnings problem. CNH’s diluted GAAP EPS ran $1.27 (FY2021) → $1.49 → $1.69 (FY2023 peak) → $0.99 → $0.41 (FY2025) → ~$0.31 TTM, an ~82% peak-to-trough collapse. The resulting 34x trailing P/E (the 88.6th percentile of CNH’s own 10-year history per the AZI valuation index) is a pure denominator illusion. The honest own-history reads are price-to-book at just the 19.4th percentile (book value ~$6.25/share, P/B 1.70x — near the cheapest third of CNH’s own range) and price-to-sales at 0.73x. For a cyclical, valuation must be anchored on mid-cycle earnings.

The normalized-EPS build (show the work). Anchoring mid-cycle industrial net sales at ~$18.5B (between the ~$22B FY2023 peak and the ~$15.5–16B FY2026 trough):

• Agriculture ~80% of industrial ≈ $14.8B × a normalized ~12.5% adjusted-EBIT margin (below the ~16–17% peak, above the 6.2% trough, with a #2-player haircut) ≈ $1.85B
• Construction ~20% ≈ $3.7B × a normalized ~6% margin ≈ $0.22B
• Industrial adj. EBIT (mid-cycle) ≈ $2.07B; less corporate/eliminations and industrial net interest ~$0.25B → industrial pre-tax ~$1.82B
• Financial Services pre-tax ~$0.55B (FS net income ~$0.40B, fairly stable)
• Consolidated pre-tax ~$2.37B; tax at ~27% → net income ~$1.73B; ÷ ~1.24B shares
• Normalized / mid-cycle EPS ≈ $1.35 (range $1.25–1.45 on Ag margins of 11.5–13%)

This sits between FY2022 ($1.49) and FY2024 ($0.99) — a defensible through-cycle center — and is ~4.4x the trough TTM GAAP figure and ~2x the FY2026 trough guide. Bulls argue the self-help program plus a LatAm recovery push normalized power toward $1.50+; bears argue the structural #2 position caps it near ~$1.00.

Comps. CNH is the cheapest of its peer set on the multiples that matter for a cyclical:

*CNH trailing P/E is distorted by trough earnings. CNH trades at 0.73x sales versus Deere’s 4.63x and 1.70x book versus 5.88x — an enormous, and largely deserved, discount reflecting #2 status and one-third-of-Deere trough margins. CAT is the opposite setup: peak earnings and a peak multiple.

Enterprise value — strip the captive book. Market cap at $10.64 × ~1.24B shares ≈ $13.2B. The aggregator “enterprise value” of ~$38B (EV/EBITDA ~11.7x) is meaningless because it counts the ~$22B Financial Services funding book as industrial leverage. Adding only Industrial net debt of $2,025M gives a proper Industrial EV of ~$15.2B, and Financial Services should be valued separately near its ~$3.5–4B equity. On mid-cycle industrial EBITDA (~$2.8B), Industrial EV/EBITDA is ~5.4x (cheap); on trough industrial EBITDA (~$1.6–1.8B), ~8.5–9.5x. The captive-finance structure makes the headline screen overstate leverage — the equity is cheaper than it looks.

Sum-of-the-parts cross-check. A crude SOTP corroborates the normalized read. Value Agriculture at a mid-cycle ~$1.85B adjusted EBIT × a ~9–10x EV/EBIT multiple (a #2 ag-equipment maker; Deere commands more) ≈ $16.5–18.5B. Value Construction at ~$0.22B mid-cycle EBIT × a ~6–7x multiple (sub-scale, possibly worth more to a strategic acquirer in the strategic review) ≈ $1.3–1.5B — call it ~$1.5B, generously. Value Financial Services at ~1x its ~$3.5–4B allocated equity ≈ $3.5–4B. Sum of enterprise/equity pieces ≈ $21.5–24B, less ~$2.0B industrial net debt ≈ $19.5–22B of equity value, versus the ~$13.2B market cap. That ~$16–18/share SOTP is a mid-cycle figure and assumes normalization; it is consistent with the ~$14–15 that ~$1.35 normalized EPS at ~10.5x implies once you haircut for execution and timing risk, and it frames the ~$10.64 price as discounting a partial, delayed normalization rather than the full mid-cycle picture. (Interpretation; illustrative, not a price target.)

Reverse-DCF / normalization sensitivity. The valuation is almost entirely a function of two variables — normalized EPS and the multiple applied — so the honest presentation is a grid, not a point. At normalized EPS of $1.00 / $1.20 / $1.35 / $1.55 and multiples of 9x / 10.5x / 12x, the implied equity value per share ranges from ~$9 (bear EPS × bear multiple) to ~$18.60 (bull EPS × bull multiple), with the base cell (~$1.35 × ~10.5x) at ~$14.2. The current $10.64 corresponds to roughly the $1.00 × ~10.5x or $1.20 × ~9x cells — i.e., the market is underwriting either structurally-impaired normalized power or a permanently-compressed #2 multiple, but not both a full recovery and a re-rating. That asymmetry — limited downside to a genuine trough valuation (P/B 19th percentile, ~8x trough-ish earnings) against meaningful upside if normalization arrives — is the crux of the setup, tempered by the real possibility that “normalized” for a structural #2 is simply lower than history suggests.

Scenario / embedded-expectations framework (no price target).

The key read. At $10.64, on normalized $1.35, CNH trades at ~7.9x mid-cycle EPS — below its own through-cycle ~9–12x and well below Deere’s ~13–14x. Reversed: apply a fair ~10.5x mid-cycle multiple and the price implies normalized EPS of only ~$1.01. So the market is not pricing trough-as-permanent (that would be ~$5–6 at 10x the trough), but it is also not crediting a full return to ~$1.35+ (that would be ~$14–15). $10.64 prices a skeptical, structurally-discounted partial recovery — roughly halfway between the trough and full normalization. The entire valuation debate reduces to one question: is CNH’s through-cycle earnings power ~$1.00 (the market’s implied, bearish view) or ~$1.35+ (the base/bull view)? (No price target; this section discusses embedded expectations only.)

11. Variant Perception

Consensus. Skeptical and mixed. JPMorgan downgraded CNH to Underweight (PT $10, maintained 2026-07-13) on farm-equipment and tariff caution; the broader sell side sits at “Hold” (roughly 6 buy / 6 hold / 1 sell, average PT ~$12.77). The consensus view: a structural #2 in a deep down-cycle, near fair value, with no near-term catalyst. The factor tape corroborates this — FactorsToday shows CNH as an abandoned-value cyclical (near-market beta ~0.9–1.06, a strong DividendYield/value loading, negative momentum and growth loadings), with a negative Sharpe across every window from six months to five years (y1 −0.52, y3 −0.30, y5 −0.15) and a lifetime max drawdown of ~91%. The one nuance: the shortest window (m3) has turned modestly positive and m6 is roughly flat — the stock has stopped falling and is base-building at the lows. This is no longer an acute falling knife (that was FY2023→FY2025), but it is not yet a momentum/recovery name either — there is no uptrend. Its factor-nearest peers are AGCO (0.95 similarity), Deere (0.94), and Terex — confirming the comp set.

The strongest bull case. 2026 is a genuine, management-confirmed cyclical trough (FY26 guided industrial margin 2.5–3.5% is a floor, not a forecast of the future). Layer on the self-help cost/margin program ($550M by 2030), a buyback shrinking the share count, an eventual LatAm/Argentina recovery, and precision-ag optionality, and normalized EPS power is ~$1.35–1.70. At ~$10.6 you pay ~8x normalized, collect ~1% while you wait, and hold a P/B at the 19th percentile of its own history — genuine value at the trough of a rational oligopoly.

The strongest bear case. CNH is a structural #2 with permanently weaker margins (single-digit trough Ag margin vs Deere’s mid-teens), facing the risk of permanent share loss to Deere’s superior, organically-built precision-ag stack. Add LatAm/Argentina/FX volatility, a sub-scale and possibly value-destroying Construction unit, rising captive-book credit losses, and an ag down-cycle that could run deeper and longer than the trough guide (used-equipment glut, higher-for-longer rates). Under this lens, normalized power is only ~$1.00, and CNH is a value trap with no re-rating catalyst — cheap because it deserves to be, and dead money until farm income turns.

The 3–5 assumptions that decide it. (1) Is FY2026 truly the trough, and does NA large-ag replacement inflect in 2027? (2) Is normalized Agriculture adjusted-EBIT margin ~12–13% (bull) or ~9–10% (bear)? (3) Does CNH hold share versus Deere, or bleed it structurally to the precision stack? (4) Does the self-help program actually lift through-cycle margins, or just offset inflation? (5) South America — recovery, or a renewed FX/demand shock?

Falsification. The bull is falsified by a third/fourth guidance cut, FY2027 industrial margin still below 5%, visible share losses to Deere in NA large ag, or self-help savings that never reach reported margins. The bear is falsified by an order-book inflection with NA large-ag retail turning up in 2027, Ag margins recovering toward low-teens, and buyback/dividend growth resuming — proving mid-cycle EPS of ~$1.35+. The factor-positioning read — maximum bearishness at the trough, base-building but unconfirmed — is exactly the setup that becomes asymmetric if the cycle turns, and a trap if it does not. This is a contrarian-value name, not a momentum one.

12. Fact vs. Interpretation Table

13. Open Questions

1. Exact “Net Debt of Industrial Activities” at Q1’26 — confirm against the 10-Q to firm up the Industrial EV rebuild (YE2025 = $2,025M used).
2. Construction strategic-review outcome and timing — sale, JV, or retain, and at what value relative to book? Material to any sum-of-the-parts and to impairment risk.
3. Brazilian Financial Services reserve adequacy — net charge-off trend versus the rising delinquency (1.9% → 3.1% → ~3.5%); is the reserve build keeping pace?
4. Aftermarket/parts revenue — undisclosed; what is the size and stability of the recurring annuity that would most support a higher through-cycle multiple?
5. Precision-ag monetization — engaged-acres / MAU-equivalent metrics CNH does not disclose; how far behind Deere’s Operations Center is the installed base, and is the gap widening or narrowing?
6. When does the destock tailwind reverse? — the FY2025 $513M industrial FCF was destock-flattered; the inventory rebuild as production normalizes to retail will consume cash — how much, and when?
7. Section 301 / broader tariff outcome — not in guidance; a potential 2027 swing factor for both segments.

14. What Must Be True

For the bull case to work (normalized EPS ~$1.35+, re-rating to ~10–11x):

• FY2026 is the cyclical bottom, and North American large-ag retail / order books inflect upward in 2027.
• Agriculture adjusted-EBIT margin recovers toward the low-teens through the cycle, with the $550M self-help program visibly lifting through-cycle (not just inflation-offsetting) margins.
• CNH holds its #2 share against Deere’s precision-ag stack — no structural bleed.
• South America / Brazil credit stabilizes and demand recovers; Financial Services risk costs normalize.
• Falsification test: a third/fourth guidance cut, FY2027 industrial margin still below 5%, visible NA large-ag share loss to Deere, or self-help savings that never reach reported margins. Any one of these breaks the bull.

For the bear case to work (normalized EPS ~$1.00, value trap):

• The ag down-cycle runs deeper/longer than the trough guide — farm income and crop prices stay depressed into 2027–28.
• CNH’s structural #2 position caps normalized Ag margins near ~9–10%, and it loses incremental share to Deere’s precision lead.
• Brazilian Financial Services credit deteriorates further, pressuring the one segment carrying group earnings.
• The self-help program merely offsets tariffs and inflation rather than expanding through-cycle margins.
• Falsification test: an order-book inflection with NA large-ag retail turning up in 2027, Ag margins recovering toward low-teens, and buyback/dividend growth resuming — proving mid-cycle EPS of ~$1.35+. Any one of these breaks the bear.

The single most important variable both cases share is the slope and timing of the ag-cycle recovery — the demand trigger (farm income) that neither management action nor the self-help program controls. That is why this is a HOLD to accumulate on weakness in Claude’s Take, and not a high-conviction position in either direction.

15. Source Appendix

See Appendix B — Source Appendix (below) for the full source list. Primary sources relied upon:

• CNH Industrial FY2025 Form 10-K (accession cnhi-20251231, filed 2026-02-26) — Business Overview, Business Segments, Note 3 Revenue, Agriculture/Construction/Financial Services MD&A and Adjusted EBIT tables, Net-Debt-to-Total-Debt reconciliation, Free-Cash-Flow-of-Industrial-Activities reconciliation, R&D/IPR&D impairment, restructuring, Financial Services credit quality. output/CNH/sources/10-K/2026-02-26_cnhi-20251231.htm
• CNH 2026 DEF 14A proxy (cnh-20260325, filed 2026-03-25) — STI/LTI metrics and weightings, CEO/CFO compensation, Exor ownership, say-on-pay.
• CNH Q1’26 / Q4’25 / Q3’25 earnings-call transcripts (ROIC.ai) and Q1’26 8-K/press release (2026-04-30, guidance).
• SEC EDGAR Form 3/4/5 corpus (since 2021-07-01) — insider-transaction read.
• ROIC.ai MCP — income statement, balance sheet, cash flow, profitability/credit ratios, per-share data, enterprise value (annual FY2019–2025), reconciled to the 10-K.
• USDA ERS Farm Sector Income Forecast (February 2026 update).
• AZI valuation index & price series; FactorsToday factor model (loadings, leaderboard, related stocks), accessed 2026-07-16/17.
• Peer references: Deere & Company (DE) and Caterpillar (CAT) public filings and disclosures, used for industry-structure, precision-ag, and cycle framing.

\pagebreak

APPENDIX A — Standard Diligence Questionnaire

CNH Industrial N.V. (NYSE: CNH) · Report date 2026-07-17 · Supplemental to the research memo (not counted toward the memo length standard).

Answers are grounded in the underlying analysis; Fact / Interpretation / Assumption labels are used where the distinction matters.

General

What thoughtful questions have other investors asked about this company? The recurring institutional debates: (1) Where is normalized earnings power? — the whole cyclical question, with bulls at ~$1.35–1.70 and bears at ~$1.00 (Interpretation). (2) Can CNH ever close the margin gap to Deere? — the 2030 Agriculture 16–17% target vs a 6.2% trough. (3) Is the captive finance book a hidden risk or a stabilizer? — Brazilian delinquencies rising into the trough. (4) What happens to Construction? — the strategic review. (5) Is the enormous discount to Deere (0.73x vs 4.6x sales) deserved or excessive? Some value-oriented managers hold it as a cheap cyclical; parts of the sell side (JPMorgan at Underweight) see a value trap.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? A cyclical low — a deep trough. FY2025 EPS $0.41 vs a FY2023 peak of $1.69 (−76%); TTM ~$0.31 (−82% peak-to-trough). Management guides FY2026 lower still (adjusted EPS $0.35–0.45; industrial margin 2.5–3.5%) and calls 2026 “the trough… probably in 20 or 30 years of ag.” (Fact.)

Driven by the external environment or internal actions? Overwhelmingly external — the ag-capex cycle, driven by farm income and crop prices (corn ~$4.20, soy ~$10.40, off the 2022 highs). Internal actions (destocking, cost-out, underproduction) manage the trough but do not cause or cure it. (Interpretation.)

How stable are revenues? Highly unstable — industrial net sales fell ~30% peak-to-trough in two years; ~85% is whole-goods equipment, the most cyclical revenue there is. The ~15% finance/lease income and undisclosed aftermarket parts are the only stabilizers. (Fact/Interpretation.)

Outlook for products/services? Cyclically depressed near-term; structurally intact long-term (aging fleet, replacement wave coiled). Precision-ag content is the secular growth vector (target ~10% of ag sales by 2030). (Interpretation.)

How big is the market — growing, shrinking, domestic or international? A large, mature, globally cyclical market (agricultural equipment worldwide, plus construction). Not secularly growing in units — it oscillates around a slowly-rising replacement trend. CNH is more international/EMEA-and-Brazil-weighted than Deere. (Fact.)

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Roughly stable in agriculture (concentrated oligopoly, rational pricing) but with an intensifying technology front (precision/autonomy), where Deere leads and CNH follows. Construction is getting more competitive (Chinese OEMs). (Interpretation.)

How profitable is the business (ROIC, ROE)? At the trough, poorly: consolidated ROE 4.9%, ROIC 4.9% (FY2025), both flattered by finance leverage; industrial ROIC is near/below cost of capital at the bottom. Through-cycle it is a mid-single-to-low-double-digit ROIC business — well below Deere’s. (Fact.)

How profitable is the industry — how many competitors, what barriers to entry? Agriculture is a profitable oligopoly (Deere, CNH, AGCO, Kubota, CLAAS) with high barriers (dealer density, brand, emissions R&D scale, precision integration, capital intensity). The profit pool is skewed to the #1 (Deere). (Fact/Interpretation.)

Can the business be easily understood? Yes — a manufacturer of tractors/combines/construction equipment bolted to a captive lender. The one subtlety that trips up newcomers: separating Industrial Activities from Financial Services in the debt/EV analysis. (Interpretation.)

Can it be undermined by foreign low-cost labor? Partially — Chinese OEMs (XCMG, SANY) pressure the low end and construction, and Kubota/Mahindra compete in small/compact ag. But large-ag (high-horsepower tractors, combines) is protected by brand, dealer support, precision technology, and emissions compliance — hard to undercut on price alone. (Interpretation.)

Do brands matter? Yes, significantly — Case IH and New Holland carry a century of farmer trust and command premium/mid pricing; brand is a core component of the moat alongside the dealer network. (Fact/Interpretation.)

What is the nature of competition? Product capability, dealer support/coverage, precision-technology integration, financing availability, and brand — not primarily price (in large ag). (Interpretation.)

Customers’ switching costs? Real but moderate — a farmer switching brands abandons familiar equipment, dealer relationships, parts/service ecosystems, and increasingly a connected-data platform. Switching costs are rising as precision/data deepens (which is precisely why CNH’s follower position on precision matters). (Interpretation.)

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The brands, dealer network, and precision-ag installed base are worth more than their carrying value; conversely, tangible book is only ~$2.50/share after $3.6B goodwill + $1.1B intangibles. (Interpretation.)

Off-balance-sheet liabilities? Nothing unusual flagged; operating leases and the securitized finance receivables are disclosed. Argentina/hyperinflation and residual-value risk in the finance/lease book are the areas to watch. (Fact/Assumption.)

How conservative is the accounting? Mixed. Positives: the Raven/Bennamann IPR&D impairment was taken promptly; restructuring is charged (not perpetually adjusted away). Watch-items: FY2025 EPS was flattered by an Argentina tax one-off and by destock-driven working-capital cash release; “adjusted” figures add back ~$244M of discrete items. Group net income leans heavily on the captive finance arm. (Interpretation.)

How CapEx-hungry is the business? Moderately — industrial CapEx ~$530M (FY2025, ~3.5% of industrial sales), guided up to $600–650M in 2026 (counter-cyclical retooling), plus $1,025M of R&D. Not as capital-intensive as heavy mining/construction pure-plays, but meaningfully more than an asset-light industrial. (Fact.)

Capital Allocation & Management

How much FCF does the business generate, and how is it used? Industrial FCF is thin and volatile: $1,216M (FY2023) → −$401M (FY2024) → $513M (FY2025, destock-flattered) → guided $150–350M (FY2026). Uses: reinvestment (R&D/CapEx), then dividends and buybacks, throttled pro-cyclically. (Fact.)

Philosophy? Reinvest → maintain a healthy balance sheet → return the rest, with capital returns cut sharply in the down-cycle to protect the balance sheet. Disciplined and correctly pro-cyclical. (Fact/Interpretation.)

Significant acquisitions recently? Raven ($2.1B, 2021, partially impaired), plus Augmenta, Hemisphere, Bennamann, and Sampierana/Eurocomach. The “Iron + Tech” precision-ag build-out — strategically necessary, expensively priced, not yet earning its keep. (Fact/Interpretation.)

Buying back shares? Yes but throttled — $702M (2024) cut to $100M (2025); ~7.6% share-count reduction over three years, but skewed to higher-price years. (Fact.)

Issuing large amounts of stock to insiders? No — dilution is modest; insider activity is routine PSU/RSU grants and tax-withholding, with no open-market purchases. (Fact.)

Compensation policy of directors/management? Well-aligned: STI on adjusted EBIT margin (40%, which paid 0% in 2025), constant-FX revenue, cash conversion, CO₂, safety; LTI on Industrial RoIC + adjusted EPS × relative TSR. CEO comp $11.72M; say-on-pay 96.15%. (Fact.)

Motivations of management? Exor’s 45.5% voting control aligns the largest owner with long-term value; the CEO’s LTI is 100% PSUs held to the fifth anniversary. Governance overhang for minorities, but incentives point the right way. (Interpretation.)

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer? No — CNH is a NYSE-listed ordinary share of a Netherlands-domiciled company that files as a U.S. domestic filer (10-K). No K-1. (Fact.) Note the Dutch loyalty/special-voting-share structure that gives Exor amplified voting rights.

Dividend policy? A variable dividend, cut in the down-cycle (FY2025 declared ~$0.25/share, ~1% yield), prioritizing balance-sheet protection over a fixed payout. (Fact.)

How profitable is the business? At the trough, minimally (4.3% industrial EBIT margin, 4.9% ROE); through-cycle, a low-double-digit-ROIC #2 — below Deere. (Fact/Interpretation.)

Is net income diverging from cash from operations? Yes, in both directions across the cycle — FY2024 had positive net income but negative industrial FCF; FY2025 industrial FCF ($513M) exceeded industrial net income (~$172M) because of a one-time destock working-capital release. Through-cycle, watch the inventory rebuild reverse the destock cash tailwind. (Fact/Interpretation.)

Risks & Downside

What factors would cause the stock to decline? A deeper/longer ag trough; farm income staying low; a third/fourth guidance cut; a Brazilian credit event in Financial Services; permanent share loss to Deere; a value-destroying Construction disposal; renewed LatAm/FX shocks; tariff escalation. (Interpretation; see risk matrix.)

Risk of a catastrophic loss? Low — sound industrial balance sheet (~$2.0B net debt), real assets, ~$18B revenue, positive trough FCF, match-funded/reserved finance book. (Interpretation.)

Chance of a total loss? Very low — this is a solvency-safe, cash-generative #2 in a rational oligopoly; the realistic downside is a value trap (dead money), not a wipeout. (Interpretation.)

Recent News & Events

Has the business environment changed recently? Yes — worse cyclically (FY2026 guided below FY2025; South America recovery thesis broke, SA ag −28% in Q1’26; FS delinquencies rising toward ~3.5%; tariffs a net headwind) but with structurally positive developments (Construction strategic review, self-help cost program, orderly CEO transition). (Fact.)

Significant acquisitions? None recent beyond the 2021–2024 precision/compact deals; the news flow is now about a potential Construction divestiture. (Fact.)

Change in accounting policies? None material flagged; the transition to U.S. domestic filer (10-K) ~2023 changed the disclosure format, not the substance. (Fact.)

Recent changes — new markets, facilities, management? Burlington, Iowa construction plant closing Q2 2026 (→ Wichita); €21M Modena logistics/simulation investment (June 2026); CEO Wine → Marx transition; May-2026 AGM re-appointments; June-2026 $600M / C$450M Financial Services note issuances. (Fact.)

\pagebreak

APPENDIX B — Source Appendix

CNH Industrial N.V. (NYSE: CNH) · Report date 2026-07-17. Primary sources first; every non-obvious fact in the memo traces to an entry here.

Primary — SEC / company filings

1. CNH Industrial FY2025 Form 10-K — accession cnhi-20251231, filed 2026-02-26. Business Overview & Segments; Note 3 Revenue (segment & geographic); Agriculture/Construction/Financial Services MD&A and Adjusted EBIT tables; Net-Debt-to-Total-Debt reconciliation (Industrial vs Financial Services); Free-Cash-Flow-of-Industrial-Activities reconciliation; R&D and the $172M IPR&D impairment (Raven/Bennamann); restructuring; Financial Services credit quality (past-due %, managed portfolio, originations). output/CNH/sources/10-K/2026-02-26_cnhi-20251231.htm — https://www.sec.gov/Archives/edgar/data/1567094/000156709426000006/cnhi-20251231.htm
2. CNH FY2024 / FY2023 / FY2022 Form 10-K — filed 2025-02-28, 2024-02-29, 2023-02-28 — multi-year segment revenue, adjusted EBIT, capital-return and share-count history.
3. CNH 2026 DEF 14A (proxy) — cnh-20260325, filed 2026-03-25. STI/LTI metrics & weightings; CEO/CFO compensation; Exor ownership (29.6% economic / 45.5% voting); say-on-pay. output/CNH/sources/DEF_14A/2026-03-25_cnh-20260325.htm
4. CNH Q1’26 8-K / press release — 2026-04-30, FY2026 guidance (industrial net sales flat to −4%; industrial EBIT margin 2.5–3.5%; adjusted EPS $0.35–0.45; industrial FCF $150–350M). https://www.sec.gov/Archives/edgar/data/0001567094/000156709426000009/ex991q126.htm
5. SEC EDGAR Form 3/4/5 corpus (since 2021-07-01) — insider-transaction read; zero code-P open-market purchases; routine PSU/RSU grants, settlements, tax-withholding and discretionary sales.
6. CNH Industrial Capital note issuances — $600M 4.950% notes due 2031 (2026-06-22) and C$450M Canadian notes (2026-06-25); Financial Services funding.

Primary — transcripts

7. CNH earnings-call transcripts (ROIC.ai): Q1 2026 (call 2026-04-30), Q4 2025 (2026-02-17), Q3 2025 (2025-11-07) — read in full for guidance, trough framing, segment outlook, South America, precision-ag, cost program, Financial Services credit, and capital allocation. Management commentary treated as hypothesis and validated against filings/USDA/peer data.

Quantitative data sources

8. ROIC.ai MCP — get_income_statement, get_balance_sheet, get_cash_flow, get_profitability_ratios, get_credit_ratios, get_per_share_data, get_enterprise_value, get_valuation_multiples, get_company_profile (annual FY2019–2025), accessed 2026-07-17; reconciled to the 10-K, with consolidated net-debt/EV explicitly overridden by the 10-K Industrial split.
9. AZI valuation index (scripts/azi.sh fundamentals CNH, 2026-07-16) — own-history percentiles: P/E 88.6th (trough-distorted), P/B 19.4th, P/S 83.3rd, composite 63.8th; book value $6.25/share.
10. AZI daily price series (download-data.php?t=CNH) — five-year OHLC (adjusted & unadjusted), EMAs, beta/alpha — basis for the five-year price map. output/CNH/2026-07-17/_scratch/CNH_prices.csv
11. FactorsToday factor model — /stock-loadings, /leaderboard, /related-stocks, /stock-specific-vol, /stock-info for CNH, accessed 2026-07-16. Factor identity (near-market beta, DividendYield/value tilt, negative momentum/growth), risk-adjusted track record (negative Sharpe y1/y3/y5; base-building m3), factor-similar peers (AGCO/DE/TEX). Third-party statistical estimates, regime-caveated.

Industry / macro / third-party

12. USDA ERS Farm Sector Income Forecast (February 2026 update) — 2026 net farm income $153.4B (−2.6% real); crop-margin and corn/soybean price context. https://www.ers.usda.gov/topics/farm-economy/farm-sector-income-finances/highlights-from-the-farm-income-forecast
13. Precision-agriculture / agritech market reports (MarketsandMarkets / ResearchAndMarkets, 2025–26) — precision-ag share estimates (Deere ~15–18%, AGCO ~7–9%, CNH lower), accessed 2026-07-17.
14. Raven Industries acquisition — CNH press release 2021-06-21; completed 2021-11-30, ~$2.1B / $58 per share; agfundernews coverage.
15. JPMorgan (Tami Zakaria) — Underweight rating, PT $10 (maintained 2026-07-13); gurufocus.com / marketscreener.com.
16. Corporate news — €21M Modena logistics/simulation investment (globenewswire 2026-06-11); 2026 AGM results (globenewswire 2026-05-08); Burlington IA plant-closure plan (2025-11-03).
17. Peer multiples — stockanalysis.com (DE / CAT / AGCO statistics, 2026-07-17).

Peer references (public)

18. Deere & Company (DE) — public SEC filings, earnings disclosures and investor materials — ag-cycle structure, market shares, precision-ag positioning, right-to-repair, and peer valuation framing.
19. Caterpillar (CAT) — public SEC filings and disclosures — construction-equipment and tariff framing.